DMT1 Polyclonal Antibody, 20??L and 1 more item

The University of Virginia awarded contract A207_PO-0448817 to Bioss Inc on August 1, 2026, for the supply of research-grade biological materials and associated logistics services. The primary deliverable consists of DMT1 Polyclonal Antibody in 20-microliter bottle units, which will be delivered to the buyer. This contract, valued at forty dollars, represents a procurement of specialized laboratory reagents in support of the contracting organization's research operations.

The contract includes shipping services as a secondary line item, with forty individual shipment units priced at one dollar each. The cumulative contract value of forty dollars encompasses both the antibody product and the associated shipping costs to the buyer. No specific performance period beyond the award date of August 1, 2026, or designated place of performance location within Virginia is identified in the available contract documentation.